ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 663

$1.1M Total Retail Price of All Prescriptions

Rank: 9 out of 663

1,084 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,084 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 1,084 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 18,128 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 1,094 932 1 3
LISINOPRIL 869 748 2 2
SIMVASTATIN 787 700 3 1
METOPROLOL TARTRATE 597 534 4 11
OMEPRAZOLE 571 471 5 4
AMLODIPINE BESYLATE 542 490 6 5
FUROSEMIDE 524 446 7 7
HYDROCODONE-ACETAMINOPHEN 523 381 S3 8 6
METFORMIN HCL 513 414 9 9
WARFARIN SODIUM 496 455 10 8
CITALOPRAM HBR 420 376 11 18
TRAMADOL HCL 409 367 12 17
METOPROLOL SUCCINATE 376 348 13 25
LOSARTAN POTASSIUM 349 300 14 14
PRAVASTATIN SODIUM 347 292 15 21
DONEPEZIL HCL 339 327 16 40
HYDROCHLOROTHIAZIDE 317 290 17 12
ATORVASTATIN CALCIUM 301 262 18 13
SERTRALINE HCL 283 223 19 35
MELOXICAM 256 245 20 61
GABAPENTIN 245 210 21 20
ATENOLOL 241 197 22 10
NAMENDA 226 211 23 57
ZOLPIDEM TARTRATE 225 212 24 16
GLIMEPIRIDE 225 209 24 84
CARVEDILOL 208 197 26 47
POTASSIUM CHLORIDE 201 171 27 23
PANTOPRAZOLE SODIUM 200 186 28 45
ALENDRONATE SODIUM 183 181 29 15
CLONIDINE HCL 173 112 30 79
TAMSULOSIN HCL 170 154 31 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 169 157 32 22
ZETIA 155 119 33 80
CLOPIDOGREL 155 126 33 65
ALLOPURINOL 145 123 35 28
LANTUS 139 103 36 48
DIOVAN 138 138 37 59
DIGOXIN 137 131 38 50
ROPINIROLE HCL 132 121 39 140
ISOSORBIDE MONONITRATE ER 132 120 39 93
FLUTICASONE PROPIONATE 131 103 41 27
AZITHROMYCIN 123 93 42 64
PREDNISONE 123 116 42 39
RAMIPRIL 115 102 44 132
FLUOXETINE HCL 111 54 45 32
AGGRENOX 111 108 45 175
PLAVIX 108 97 47 104
KLOR-CON M20 106 90 48 70
JANUVIA 105 96 49 78
GLYBURIDE 104 73 R 50 83
TRAZODONE HCL 102 93 51 34
MORPHINE SULFATE ER 97 72 S2 52 51
GEMFIBROZIL 96 90 53 109
ADVAIR DISKUS 96 62 53 53
CYMBALTA 94 84 55 54
LYRICA 92 60 56 96
SPIRIVA 90 85 57 62
PROAIR HFA 86 43 58 33
DOXAZOSIN MESYLATE 85 76 59 73
OXYCODONE HCL 84 63 S2 60 41
HYDRALAZINE HCL 84 52 60 101
NEXIUM 82 38 62 43
CRESTOR 80 53 63 37
VENLAFAXINE HCL 79 74 64 166
OLANZAPINE 77 77 65 88
FENTANYL 77 49 S2 65 75
LOSARTAN-HYDROCHLOROTHIAZIDE 75 72 67 60
CYCLOBENZAPRINE HCL 75 37 R 67 71
EVISTA 70 68 69 150
OXYCODONE-ACETAMINOPHEN 68 54 S2 70 26
LIPITOR 66 61 71 72
LANTUS SOLOSTAR 64 53 72 161
TRIAMTERENE-HCTZ 64 47 72 42
INSULIN SYRINGE 63 40 74 55
ACTOS 62 54 75 105
AMOX TR-POTASSIUM CLAVULANATE 60 51 76 193
FOSINOPRIL SODIUM 60 60 76 213
COMBIVENT 59 59 78 125
FINASTERIDE 59 58 78 56
SINGULAIR 58 43 80 222
OXYBUTYNIN CHLORIDE 56 43 81 99
SPIRONOLACTONE 56 42 81 58
QUETIAPINE FUMARATE 54 35 83 69
SYNTHROID 51 37 84 46
LEVOXYL 51 39 84 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.